10x Genomics: New AI Partnership and Optimized Platform Revolutionize Cell Biology
Reading Time: 3 minutes
The life science technology company caught my attention this week as one of the fastest-growing stocks in the megatrend "E-Health." After 10x published its figures for the third quarter of 2025 yesterday, on November 6, 2025, a complete picture emerges that looks promising for the future. In the calendar year 2024, the 10x stock suffered significantly more than the company's development would suggest. As the low point was likely reached in early April 2025 and the stock has risen by 65% in the last six months, it may be a good time for investors...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.

